Senior insider sale
ACADIA PHARMACEUTICALS INC — senior position signals high conviction
$671.0K
30K shares
What this filing means
DALY JAMES M plans to sell 30K shares of ACADIA PHARMACEUTICALS INC valued at approximately $671.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/10/2025ACC: 0001950047-25-008659
30K
Shares to sell
$671.0K
Approx. market value
30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Restricted Stock
Not Applicable
5/29/2025
5.35KRestricted Stock
Not Applicable
5/29/2024
6.65KRestricted Stock
Not Applicable
6/1/2023
8.55KRestricted Stock
Not Applicable
6/7/2022
6.39KRestricted Stock
Not Applicable
6/22/2021
3.06KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/29/2025 | Restricted Stock Not Applicable | 5.35K | — |
5/29/2024 | Restricted Stock Not Applicable | 6.65K | — |
6/1/2023 | Restricted Stock Not Applicable | 8.55K | — |
6/7/2022 | Restricted Stock Not Applicable | 6.39K | — |
6/22/2021 | Restricted Stock Not Applicable | 3.06K | — |
| Total | 30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
30K
Market value
$671.0K
11/10/2025
Total
Units
30K
Value
$671.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/10/2025 | 30K | $671.0K | NASDAQ | Planned |
| Total | 30K | $671.0K | ||